rVSV Sudan ebola virus vaccine (Emergent BioSolutions)

N/A

Report date: 2024/03/14 18:32:18

Base Information

Drug NamerVSV Sudan ebola virus vaccine (Emergent BioSolutions)
Drug Alias NamerVSV-Sudan (Emergent Biosolutions)rVSV-vectored vaccine for Sudan virus disease (Emergent BioSolutions)EBS-Sudan (Emergent Biosolutions)
ClassificationVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Synthetic peptide vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHemorrhagic Fever, Ebola
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAuro Vaccines Llc
China Registration ClassN/A

Develop Information

Active CompaniesEmergent Biosolutions Inc
Inactive CompaniesN/A
Active IndicationsHemorrhagic Fever, Ebola
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A